Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Discussions related to drug importation and IPAB (S.319, H.R. 147, H.R. 452) Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #) Discussions regarding the Patient Protection and Affordable Care Act
Discussions related to drug importation and IPAB (S.319, H.R. 147, H.R. 452) Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #) Discussions regarding the Patient Protection and Affordable Care Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2013 · first_quarter · Q1
Discussions regarding FY 2013 budget
Discussions regarding Medicare Part D
Discussions related to drug importation and IPAB
Source: Senate LDA
Medicare Prescription Drug Price Negotiation Act of 2011
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
Discussions regarding Medicare Part D (H.R.2248/S. 44)
Medicare Prescription Drug Price Negotiation Act of 2011
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
Discussions regarding Medicare Part D (H.R.2248/S. 44)
Medicare Decisions Accountability Act of 2011
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
Discussions related to drug importation and IPAB (S.319, H.R. 147, H.R. 452) Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #) Discussions regarding the Patient Protection and Affordable Care Act
Medicare Decisions Accountability Act of 2011
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
Discussions related to drug importation and IPAB (S.319, H.R. 147, H.R. 452) Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #) Discussions regarding the Patient Protection and Affordable Care Act
Food and Drug Administration Reform Act of 2012
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
Discussions related to drug importation and IPAB; Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #); Discussions regarding healthcare reform; Discussions regarding the Food and Drug Administration Reform Act (H.R. 5651); Discussions regarding Drug Safety and Accountability Act (S.1584)
Food and Drug Administration Reform Act of 2012
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
Discussions related to drug importation and IPAB; Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #); Discussions regarding healthcare reform; Discussions regarding the Food and Drug Administration Reform Act (H.R. 5651); Discussions regarding the Food and Drug Administration Safety and Innovation Act (S.3187).
Discussions related to drug importation and IPAB (S.319, S. 688, H.R. 147, H.R.2112/Admt769) Discussions related to budget and debt ceiling (S.365) Discussions regarding drug shortages (H.R. 2245, S. 296)
Repealing the Job-Killing Health Care Law Act
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
Discussions related to healthcare repeal, healthcare reform, issues relating to drug importation and IPAB (H.R. 2, H.R. 452) Discussions regarding budget (CR, H3082)
Repealing the Job-Killing Health Care Law Act
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
Discussions related to healthcare repeal, healthcare reform, issues relating to drug importation and IPAB (H.R. 2, H.R. 452. S. 688) Discussions regarding budget continuing resolution (H.R.1473, HJRes. 48, HCon Res 34) Discussions regarding Medicare Part D
Discussions regarding Medicare Part D (H.R.2190, S. 44)
Preserving Access to Life-Saving Medications Act of 2011
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
Discussions related to drug importation and IPAB (S.319, S. 688, H.R. 147, H.R.2112/Admt769) Discussions related to budget and debt ceiling (S.365) Discussions regarding drug shortages (H.R. 2245, S. 296)
Discussions regarding Medicare Part D (H.R.2693/Joint Committee on Deficit Reduction)
Medicare Decisions Accountability Act of 2011
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
Discussions related to healthcare repeal, healthcare reform, issues relating to drug importation and IPAB (H.R. 2, H.R. 452) Discussions regarding budget (CR, H3082)
Medicare Decisions Accountability Act of 2011
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
Discussions related to healthcare repeal, healthcare reform, issues relating to drug importation and IPAB (H.R. 2, H.R. 452. S. 688) Discussions regarding budget continuing resolution (H.R.1473, HJRes. 48, HCon Res 34) Discussions regarding Medicare Part D
Medicare Decisions Accountability Act of 2010
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
P.L.111-148 - Healthcare reform law and possible modification of certain sections; General discussion related to drug pricing issues (no specific legislation); HR 4985, Medicare Decisions Accountability Act of 2010
Medicare Decisions Accountability Act of 2010
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 759 - Food and Drug Administration Globalization Act of 2009, all provisions H.R. 4985 - Medicare Decisions Accountability Act of 2010, all provisions Discussions regarding drug product importation
Food and Drug Administration Globalization Act of 2009
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 759 - Food and Drug Administration Globalization Act of 2009, all provisions H.R. 4985 - Medicare Decisions Accountability Act of 2010, all provisions Discussions regarding drug product importation
Financial Services and General Government Appropriations Act, 2011
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 4899, Supplemental Appropriations Act, 2010, provisions regarding patent settlements S.3677, Financial Services and General Government Appropriations Act, 2011, provisions regarding patent settlements
Financial Services and General Government Appropriations Act, 2011
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
S.3677/S.369 - Financial Services and General Government Appropriations Act, 2011, provisions related to patent settlements
Preserve Access to Affordable Generics Act
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
S.3677/S.369 - Financial Services and General Government Appropriations Act, 2011, provisions related to patent settlements
American Middle Class Tax (AMT) Relief Act of 2007
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R. 3590 - The Patient Protection and Affordable Care Act; issues relating to drug importation.
American Middle Class Tax (AMT) Relief Act of 2007
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R. 3590 - The Patient Protection and Affordable Care Act; issues relating to drug importation.
H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R. 3590 - The Patient Protection and Affordable Care Act; issues relating to drug importation.
H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R. 3590 - The Patient Protection and Affordable Care Act; issues relating to drug importation.
Community-Based Mental Health Infrastructure Improvements Act
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 4899, Supplemental Appropriations Act, 2010, provisions regarding patent settlements S.3677, Financial Services and General Government Appropriations Act, 2011, provisions regarding patent settlements
Community-Based Mental Health Infrastructure Improvements Act
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 4899, Supplemental Appropriations Act, 2010
Comparative Effectiveness Research Act of 2009
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 3200 - America's Affordable Health Choices Act of 2009, provisions related to importation of drugs; H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R.2502 - Comparative Effectiveness Research Act of 2009, all provisions; S. 525 - Pharmaceutical Market Access and Drug Safety Act of 2009, provisions related to drug importation; H.R. 3590 - The Patient Protection and Affordable Care Act; S.1796 - America's Healthy Future Act
Comparative Effectiveness Research Act of 2009
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 2892 - Dept. of Homeland Security Appropriations H.R. 3200 - America's Affordable Health Choices Act of 2009 H.R. 2502 - Comparative Effectiveness Research Act of 2009 Bio similars data exclusivity; Senate Finance Healthcare reform
America's Affordable Health Choices Act of 2009
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 3200 - America's Affordable Health Choices Act of 2009, provisions related to importation of drugs; H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R.2502 - Comparative Effectiveness Research Act of 2009, all provisions; S. 525 - Pharmaceutical Market Access and Drug Safety Act of 2009, provisions related to drug importation; H.R. 3590 - The Patient Protection and Affordable Care Act; S.1796 - America's Healthy Future Act
America's Affordable Health Choices Act of 2009
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 2892 - Dept. of Homeland Security Appropriations H.R. 3200 - America's Affordable Health Choices Act of 2009 H.R. 2502 - Comparative Effectiveness Research Act of 2009 Bio similars data exclusivity; Senate Finance Healthcare reform
H.R. 3200 - America's Affordable Health Choices Act of 2009, provisions related to importation of drugs; H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R.2502 - Comparative Effectiveness Research Act of 2009, all provisions; S. 525 - Pharmaceutical Market Access and Drug Safety Act of 2009, provisions related to drug importation; H.R. 3590 - The Patient Protection and Affordable Care Act; S.1796 - America's Healthy Future Act
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 3200 - America's Affordable Health Choices Act of 2009, provisions related to importation of drugs; H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R.2502 - Comparative Effectiveness Research Act of 2009, all provisions; S. 525 - Pharmaceutical Market Access and Drug Safety Act of 2009, provisions related to drug importation; H.R. 3590 - The Patient Protection and Affordable Care Act; S.1796 - America's Healthy Future Act
Family Smoking Prevention and Tobacco Control Act
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
S. 982 - Family Smoking Prevention & Tobacco Control Act (issues related to drug product importation amendment) General issues related to drug product importation
H.R. 2892 - Dept. of Homeland Security Appropriations H.R. 3200 - America's Affordable Health Choices Act of 2009 H.R. 2502 - Comparative Effectiveness Research Act of 2009 Bio similars data exclusivity; Senate Finance Healthcare reform
American Middle Class Tax (AMT) Relief Act of 2007
Client: DAIICHI SANKYO INC · Firm: DAIICHI SANKYO, INC.
H.R. 3200 - America's Affordable Health Choices Act of 2009, provisions related to importation of drugs; H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R.2502 - Comparative Effectiveness Research Act of 2009, all provisions; S. 525 - Pharmaceutical Market Access and Drug Safety Act of 2009, provisions related to drug importation; H.R. 3590 - The Patient Protection and Affordable Care Act; S.1796 - America's Healthy Future Act
H.R. 3200 - America's Affordable Health Choices Act of 2009, provisions related to importation of drugs; H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R.2502 - Comparative Effectiveness Research Act of 2009, all provisions; S. 525 - Pharmaceutical Market Access and Drug Safety Act of 2009, provisions related to drug importation; H.R. 3590 - The Patient Protection and Affordable Care Act; S.1796 - America's Healthy Future Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2012 · fourth_quarter · Q4
Discussions related to drug importation; Discussions regarding healthcare reform; Discussions regarding the Food and Drug Administration user fees and issues regarding drug distribution.
Discussions regarding intellectual property protection and innovation.
Discussions regarding Medicare Part D including rebates for deficit reduction Discussions regarding 340B program Discussions regarding sequestration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2012 · third_quarter · Q3
Discussions related to drug importation and IPAB; Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #); Discussions regarding healthcare reform; Discussions regarding the Food and Drug Administration Reform Act (H.R. 5651); Discussions regarding Drug Safety and Accountability Act (S.1584)
Discussions regarding intellectual property protection and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2012 · first_quarter · 1A
Discussions regarding Medicare Part D (H.R.2248/S. 44)
Discussions regarding intellectual property protection and innovation.
Discussions related to drug importation and IPAB (S.319, H.R. 147, H.R. 452) Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #) Discussions regarding the Patient Protection and Affordable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2012 · second_quarter · Q2
Discussions related to drug importation and IPAB; Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #); Discussions regarding healthcare reform; Discussions regarding the Food and Drug Administration Reform Act (H.R. 5651); Discussions regarding the Food and Drug Administration Safety and Innovation Act (S.3187).
Discussions regarding intellectual property protection and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2012 · first_quarter · Q1
Discussions regarding intellectual property protection and innovation.
Discussions regarding Medicare Part D (H.R.2248/S. 44)
Discussions related to drug importation and IPAB (S.319, H.R. 147, H.R. 452) Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #) Discussions regarding the Patient Protection and Affordable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2011 · fourth_quarter · Q4
Discussions regarding intellectual property protection and innovation. Discussions related to patent settlements (S. 27)
Discussions related to drug importation and IPAB (S.319, S. 688, H.R. 147, H.R.2112/Admt769) Discussions related to budget and debt ceiling (S.365) Discussions regarding drug shortages (H.R. 2245, S. 296)
Discussions regarding Medicare Part D (H.R.2693/Joint Committee on Deficit Reduction)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2011 · third_quarter · Q3
Discussions regarding intellectual property protection and innovation. Discussions related to patent settlements (S. 27)
Discussions related to drug importation and IPAB (S.319, S. 688) Discussions related to budget and debt ceiling (S.365)
Discussions regarding Medicare Part D (H.R.2190, S. 44)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2011 · second_quarter · Q2
Discussions related to healthcare repeal, healthcare reform, issues relating to drug importation and IPAB (H.R. 2, H.R. 452. S. 688) Discussions regarding budget continuing resolution (H.R.1473, HJRes. 48, HCon Res 34) Discussions regarding Medicare Part D
Discussions regarding patent reform, intellectual property protection, innovation and patent settlements (S. 23)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2011 · first_quarter · Q1
Discussions related to healthcare repeal, healthcare reform, issues relating to drug importation and IPAB (H.R. 2, H.R. 452) Discussions regarding budget (CR, H3082)
Discussions regarding patent reform, innovation and patent settlements (S. 23, S.319, S.27)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2010 · fourth_quarter · Q4
P.L.111-148 - Healthcare reform law and possible modification of certain sections; General discussion related to drug pricing issues (no specific legislation); HR 4985, Medicare Decisions Accountability Act of 2010
S.3677/S.369 - Financial Services and General Government Appropriations Act, 2011, provisions related to patent settlements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2010 · third_quarter · Q3
H.R. 4899, Supplemental Appropriations Act, 2010, provisions regarding patent settlements S.3677, Financial Services and General Government Appropriations Act, 2011, provisions regarding patent settlements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2010 · first_quarter · 1A
H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R. 3590 - The Patient Protection and Affordable Care Act; issues relating to drug importation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2010 · second_quarter · Q2
H.R. 4213 - American Jobs and Closing Tax Loopholes Act of 2010, provisions regarding tax extenders
H.R. 4899, Supplemental Appropriations Act, 2010
H.R. 759 - Food and Drug Administration Globalization Act of 2009, all provisions H.R. 4985 - Medicare Decisions Accountability Act of 2010, all provisions Discussions regarding drug product importation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2010 · first_quarter · Q1
H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R. 3590 - The Patient Protection and Affordable Care Act; issues relating to drug importation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2009 · fourth_quarter · Q4
H.R. 3200 - America's Affordable Health Choices Act of 2009, provisions related to importation of drugs; H.R. 3962 - Affordable Care for America Act, provisions related to dual eligibles, medicaid rebates, 340B, biosimilars; H.R.2502 - Comparative Effectiveness Research Act of 2009, all provisions; S. 525 - Pharmaceutical Market Access and Drug Safety Act of 2009, provisions related to drug importation; H.R. 3590 - The Patient Protection and Affordable Care Act; S.1796 - America's Healthy Future Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2009 · third_quarter · Q3
H.R. 2892 - Dept. of Homeland Security Appropriations H.R. 3200 - America's Affordable Health Choices Act of 2009 H.R. 2502 - Comparative Effectiveness Research Act of 2009 Bio similars data exclusivity; Senate Finance Healthcare reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIICHI SANKYO INC via DAIICHI SANKYO, INC.
2009 · second_quarter · Q2
S. 982 - Family Smoking Prevention & Tobacco Control Act (issues related to drug product importation amendment) General issues related to drug product importation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE